Gardacil May Provide Prophylaxis against HPV Associated Oropharyngeal Cancers in Both Males and Females January 30, 2010. Jorma Jyrkkanen

Gardacil May Provide Prophylaxis against HPV Associated Oropharyngeal Cancers in Both Males and Females January 30, 2010 Gardacil May Provide Prophylaxis against HPV Associated Oropharyngeal Cancers in Both Males and Females 29 January 2010 Because HPV(16-mostly) has now been associated with some proportion of oropharyngeal squamous cell carcinomas it follows that like the case for cervical cancers, prophylaxis might provide immunity from HPV induced carcinogenesis. While Gardacil might not provide protection against cancers caused by kissing disease infectious mononucleosis (EBV) viruses originated nasopharyngeal cancers it might work with HPV oropharyngeal cancers, it does suggest the same avenue for prevention, ie: immune prophylaxis. I suggest we give boys as well as girls, prophylaxis against both EBV and HPV viral induced cancers of the head, neck, nose and throat region. Large number of life time partners in vaginal sex and oral sex had high associations with oropharyngeal cancers in a study reported in the NEJM (http://content.nejm.org/cgi/content/full/356/19/1944). In the absence of prophylaxis lifestyle choices and reducing the number of sexual partners should reduce the overall risk of these acquired viral induced cancers. Copyright 2010 Jorma Jyrkkanen. All rights reserved (except NEJM content). Tags: Gardacil, cancers, head and neck, HPV, oropharyngeal, prophylaxis, EBV, pediatrics, Jorma Jyrkkanen